fluoxetine has been researched along with phorbol 12,13-dibutyrate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
Hrdina, PD; Mann, CD; Vu, TB | 1 |
Azmitia, EC; Kramer, HK; Poblete, JC | 1 |
1 review(s) available for fluoxetine and phorbol 12,13-dibutyrate
Article | Year |
---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
2 other study(ies) available for fluoxetine and phorbol 12,13-dibutyrate
Article | Year |
---|---|
Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine.
Topics: Amphetamines; Animals; Antidepressive Agents; Autoradiography; Binding, Competitive; Cerebral Cortex; Desipramine; Fluoxetine; Hippocampus; Injections, Intraperitoneal; Male; Paraventricular Hypothalamic Nucleus; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Signal Transduction | 1995 |
Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
Topics: Animals; Binding Sites; Brain; Brain Stem; Carrier Proteins; Cerebral Cortex; Enzyme Activation; Female; Fluoxetine; Hippocampus; Ketanserin; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins | 1997 |